PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.26%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
13.78%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
60.88%
Positive EBIT growth while 3141.T is negative. John Neff might see a substantial edge in operational management.
78.82%
Operating income growth above 1.5x 3141.T's 0.59%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
59.23%
Net income growth above 1.5x 3141.T's 9.40%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
55.38%
EPS growth above 1.5x 3141.T's 9.55%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
55.38%
Diluted EPS growth above 1.5x 3141.T's 9.55%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
385.68%
OCF growth under 50% of 3141.T's 31568.75%. Michael Burry might suspect questionable revenue recognition or rising costs.
294.03%
FCF growth 50-75% of 3141.T's 564.85%. Martin Whitman would see if structural disadvantages exist in generating free cash.
10.87%
10Y revenue/share CAGR above 1.5x 3141.T's 7.18%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
10.87%
5Y revenue/share CAGR above 1.5x 3141.T's 7.18%. David Dodd would look for consistent product or market expansions fueling outperformance.
10.87%
3Y revenue/share CAGR above 1.5x 3141.T's 7.18%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
20.32%
10Y OCF/share CAGR under 50% of 3141.T's 512.74%. Michael Burry would worry about a persistent underperformance in cash creation.
20.32%
Below 50% of 3141.T's 512.74%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
20.32%
3Y OCF/share CAGR under 50% of 3141.T's 512.74%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
23.37%
Net income/share CAGR at 50-75% of 3141.T's 38.22%. Martin Whitman might question if the firm’s product or cost base lags behind.
23.37%
5Y net income/share CAGR at 50-75% of 3141.T's 38.22%. Martin Whitman might see a shortfall in operational efficiency or brand power.
23.37%
3Y net income/share CAGR 50-75% of 3141.T's 38.22%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
22.09%
10Y equity/share CAGR above 1.5x 3141.T's 9.03%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
22.09%
5Y equity/share CAGR above 1.5x 3141.T's 9.03%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
22.09%
3Y equity/share CAGR above 1.5x 3141.T's 9.03%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-61.67%
Cut dividends over 10 years while 3141.T stands at 26946.24%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-61.67%
Negative 5Y dividend/share CAGR while 3141.T stands at 26946.24%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-61.67%
Negative near-term dividend growth while 3141.T invests at 26946.24%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
No Data
No Data available this quarter, please select a different quarter.
-0.54%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
10.14%
Asset growth above 1.5x 3141.T's 2.13%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.28%
BV/share growth above 1.5x 3141.T's 3.31%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
11.04%
We have some new debt while 3141.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.